Wave Life Sciences Ltd. revenue breakdown overview

Wave Life Sciences Ltd. revenue for the last year amounted to 113.31 M USD, the most of which — 113.31 M USD — came from its highest performing source at the moment, Stereopure Oligonucleotides, the year earlier bringing 3.65 M USD. The greatest contribution to the revenue figure was made by Singapore, United States, Japan, United Kingdom, and Ireland — last year it brought Wave Life Sciences Ltd. 113.31 M USD, and the year before that — 3.65 M USD.